CUSIP: 45782C102
Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / IBD 50 ETF
-
Total 13F shares
-
1,157,590
-
Share change
-
+101,637
-
Total reported value
-
$25,772,260
-
Put/Call ratio
-
12%
-
Price per share
-
$22.38
-
Number of holders
-
40
-
Value change
-
+$1,632,588
-
Number of buys
-
13
-
Number of sells
-
24
Quarterly Holders Quick Answers
What is CUSIP 45782C102?
CUSIP 45782C102 identifies FFTY - INNOVATOR ETFS TRUST - IBD 50 ETF in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2023
-
Previous quarter:
Q2 2023
Recent filing periods for CUSIP 45782C102:
Institutional Holders of INNOVATOR ETFS TRUST - IBD 50 ETF (FFTY) as of Q3 2023
As of 30 Sep 2023,
INNOVATOR ETFS TRUST - IBD 50 ETF (FFTY) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,157,590 shares.
The largest 10 holders included
IronBridge Private Wealth, LLC, LJI Wealth Management, LLC, Chicago Partners Investment Group LLC, Del-Sette Capital Management, LLC, Royal Bank of Canada, BANK OF AMERICA CORP /DE/, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, LPL Financial LLC, and IHT Wealth Management, LLC.
This page lists
40
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.